Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Repeated-use Middle Cut Off Membrane Dialyzers on Middle Molecule Uremic Toxin and Inflammatory Cytokine Clearances in Hemodialysis Patients

NCT06950944 is registered in ClinicalTrials.gov with Khon Kaen University as lead sponsor.

NCT NCT06950944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06950944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Repeated-use Middle Cut Off Membrane Dialyzers on Middle Molecule Uremic Toxin and Inflammatory Cytokine Clearances in Hemodialysis Patients
Lead sponsor
Khon Kaen University
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2024
Completion date
April 30, 2024
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dialysis adequacy, hemodialysis, hemodialysis treatment